Taiwanese Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Eusol BiotechLtd

Market Cap: NT$835.7m

Focuses on research and development of new biotech drugs for sleep disorders.

Formosa Pharmaceuticals

Market Cap: NT$4.2b

A clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan.

Intelligene

Market Cap: NT$6.4b

Engages in the development of RNA gene therapy drugs for infectious diseases.

EirGenix

Market Cap: NT$19.2b

Operates as a contract development and manufacturing company in Taiwan and internationally.

PharmaEngine

Market Cap: NT$13.0b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

PhytoHealth

Market Cap: NT$3.0b

Researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and dietary supplements in Taiwan.

Savior Lifetec

Market Cap: NT$6.8b

A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.

StemCyte International

Market Cap: NT$4.8b

Operates cord blood cell banks in the United States and Taiwan.

Orient Pharma

Market Cap: NT$7.1b

Engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally.

Maxigen Biotech

Market Cap: NT$3.9b

Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.

Shine-On BioMedicalLtd

Market Cap: NT$3.3b

Research, develops, and manufactures anti-cancer related drug products.

TCM Biotech International

Market Cap: NT$3.4b

A biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases.

HeXun Biosciences

Market Cap: NT$3.3b

Engages in the research and development of stem cell and treatments in Taiwan.

Advagene Biopharma

Market Cap: NT$1.0b

Engages in the research and development of vaccine technology and related products in Taiwan.

Sunhawk Vision Biotech

Market Cap: NT$5.0b

Operates as a drug development company that develops microRNA therapeutic eye drops.

Holy Stone Healthcare

Market Cap: NT$1.0b

Develops and sells hyaluronic acid related therapeutic products.

CHO Pharma

Market Cap: NT$8.6b

Engages in research and development of biotechnology in Taiwan.

Synmosa Biopharma

Market Cap: NT$15.5b

A specialty pharmaceutical company, researches, develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan.

BIONET Therapeutics

Market Cap: NT$3.0b

A biopharmaceutical company, develops cell therapy products and drug development for acute and severe diseases.

Sinew Pharma

Market Cap: NT$3.6b

A biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases.

ScinoPharm Taiwan

Market Cap: NT$13.4b

Research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, India, the United States and internationally.

TaiwanJ Pharmaceuticals

Market Cap: NT$624.2m

A specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan.

Oneness Biotech

Market Cap: NT$28.0b

Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products primarily in Taiwan.

Alar Pharmaceuticals

Market Cap: NT$10.0b

A drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan.

Ever Supreme Bio Technology

Market Cap: NT$13.6b

Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.

Standard Chemical & Pharmaceutical

Market Cap: NT$10.5b

Standard Chemical & Pharmaceutical Co. Ltd.

TaiRx

Market Cap: NT$2.7b

Focuses on the development and commercialization of therapeutics for the treatment of cancer and other diseases.

PharmaEssentia

Market Cap: NT$166.4b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

GlycoNex Incorporation

Market Cap: NT$2.7b

Engages in the development of cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies in Taiwan.

Senhwa Biosciences

Market Cap: NT$3.1b

A drug development company, engages in the development of new drugs and targeted agents.

Pharmosa Biopharm

Market Cap: NT$5.7b

A biotechnology company, focuses on developing drugs in Taiwan.

BRIM Biotechnology

Market Cap: NT$3.0b

A clinical-stage company, engages in the development of novel regenerative therapies to combat and cure ophthalmology and degenerative joint diseases.

Vectorite Biomedical

Market Cap: NT$569.0m

Engages in the research and development of biotechnology in Taiwan and internationally.

Abnova (Taiwan)

Market Cap: NT$1.9b

Manufactures and sells various recombinant proteins and antibodies.

UnicoCell Biomed

Market Cap: NT$3.9b

Engages in the research and development of stem cell drugs, cell therapy technology, and regenerative medical services in Taiwan.

AnnJi Pharmaceutical

Market Cap: NT$2.4b

Develops drugs in the therapeutic areas of neurology, dermatology, and inflammatory disorders.